Quantcast
Last updated on April 23, 2014 at 21:23 EDT

Latest Lisdexamfetamine Stories

2014-04-07 23:26:22

New supplement by Nature Optimized aims to naturally heal ADHD and the addictive brain. Spanish Fork, UT (PRWEB) April 07, 2014 Filling a much-needed gap in the ADHD supplement market, Nature Optimized makes liquid supplements with a unique, proprietary blend of fats and amino acids plus brain-supporting vitamins and minerals that is safe for children as well as pregnant women. The first formula, Pure Clarity Calm, increases focus and motivation while calming the active mind. The second...

2014-04-07 12:33:42

Contest for adults who struggle with organization PHILADELPHIA, April 7, 2014 /PRNewswire/ -- Shire today announced the launch of the Organize Your Stuff contest, which is designed for adults who want help organizing their space and reducing clutter. The contest includes the support of expert organizer Monica Friel, president and founder of Chaos to Order, a respected professional organizing service. To enter, adults ages 18 and over can submit a photo to OrganizeYourStuffContest.com. The...

2014-02-06 16:28:08

DUBLIN, February 6, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces top-line results from two pivotal Phase 3 investigational studies evaluating the efficacy and safety of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules (CII) versus placebo as an adjunctive treatment for major depressive disorder (MDD) in adults who inadequately responded to antidepressant monotherapy with a SSRI or SNRI. Vyvanse did not meet the primary efficacy endpoint versus placebo for...

2013-11-05 04:23:21

DUBLIN, November 5, 2013 /PRNewswire/ -- Shire Plans to Submit a Supplemental New Drug Application (sNDA) by Q3 2014 Shire plc (LSE: SHP, NASDAQ: SHPG) announces positive top-line results from two identically designed randomized placebo-controlled Phase 3 studies evaluating the efficacy and safety of Vyvanse(R) (lisdexamfetamine dimesylate) Capsules (CII) versus placebo in adults with binge eating disorder (BED). In both studies Vyvanse was found to be statistically...

2013-10-31 23:23:19

MedicationDiscountCard.com Now Offers Minastrin 24 Fe Coupon Margate, NJ (PRWEB) October 31, 2013 Health care expenses are on everybody's mind these days. With the coming implementation of the Affordable Care Act, there's a lot of talk about what it will do to the cost of healthcare—especially for those who already have health insurance. Studies show that 98% of sexually active women aged 15-44 have used some method of birth control. While birth control pills offer more...

2013-07-15 08:27:18

30-Year Investment Banking Veteran Joins KemPharm to Strengthen its Business & Financial Operations NORTH LIBERTY, Iowa, July 15, 2013 /PRNewswire/ -- KemPharm, Inc., a clinical stage biopharmaceutical company focused on the discovery and development of new, safer therapies to treat pain, announced today the appointment of Gordon K. "Rusty" Johnson as Chief Operating Officer (COO) and Chief Financial Officer (CFO). As COO and CFO of KemPharm, Mr. Johnson will join KemPharm's...

2013-06-25 08:29:13

-- Positive results achieved in Phase 1 HLD-200 study ; confirm second pipeline product -- Results further validate Highland's drug-delivery technology as potential platform technology -- Study highlights include class-leading low variability with respect to Tmax -- Consistent delay in initial drug release, in conjunction with a long absorption window, further support HLD-200's commercial...

2013-05-17 12:23:14

PHILADELPHIA, May 17, 2013 /PRNewswire/ -- Research explores data on treatments for psychiatric disorders; health economics and outcomes research also to be presented Shire plc (LSE: SHP, NASDAQ: SHPG), the global specialty biopharmaceutical company, announces that it will present scientific data in 7 poster presentations at the American Psychiatric Association (APA) 166th Annual Meeting in San Francisco, May 18-22. The data being presented...

2013-05-01 16:30:28

Becomes the first stimulant medication approved for maintenance treatment in patients ages 6 and above with ADHD PHILADELPHIA, May 1, 2013 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) approved the prescription medication Vyvanse(R) (lisdexamfetamine dimesylate) Capsules, (CII) as a maintenance treatment in children and adolescents with...

2013-03-12 08:30:00

FDA, peer-reviewed research support effectiveness of Vyvanse® as an ADHD treatment MARGATE CITY, N.J., March 12, 2013 /PRNewswire/ -- MDC announces the availability of a Vyvanse coupon through its website, redeemable towards prescriptions of Vyvanse from pharmacies. The coupon can be accessed from the bottom portion of http://medicationdiscountcard.com/drug/vyvanse-coupon/ to save up to 50% on your copay. Vyvanse (lisdexamfetamine dimesylate) is an FDA-approved medication used...